DE602006007211D1 - Neue kristalline und stabile Form von Andolast - Google Patents

Neue kristalline und stabile Form von Andolast

Info

Publication number
DE602006007211D1
DE602006007211D1 DE602006007211T DE602006007211T DE602006007211D1 DE 602006007211 D1 DE602006007211 D1 DE 602006007211D1 DE 602006007211 T DE602006007211 T DE 602006007211T DE 602006007211 T DE602006007211 T DE 602006007211T DE 602006007211 D1 DE602006007211 D1 DE 602006007211D1
Authority
DE
Germany
Prior art keywords
andolast
new crystalline
stable form
conditions
disodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006007211T
Other languages
English (en)
Inventor
Antonio Giordani
Paolo Senin
Francesco Makovec
Walter Peris
Lucio Claudio Rovati
Antonino Santoro
Matteo Ghirri
Paola Gilotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rottapharm SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm SpA filed Critical Rottapharm SpA
Publication of DE602006007211D1 publication Critical patent/DE602006007211D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicinal Preparation (AREA)
DE602006007211T 2006-04-10 2006-04-10 Neue kristalline und stabile Form von Andolast Active DE602006007211D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112427A EP1845093B1 (de) 2006-04-10 2006-04-10 Neue kristalline und stabile Form von Andolast

Publications (1)

Publication Number Publication Date
DE602006007211D1 true DE602006007211D1 (de) 2009-07-23

Family

ID=36942320

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006007211T Active DE602006007211D1 (de) 2006-04-10 2006-04-10 Neue kristalline und stabile Form von Andolast

Country Status (11)

Country Link
US (2) US7824710B2 (de)
EP (1) EP1845093B1 (de)
JP (1) JP5265876B2 (de)
AT (1) ATE433443T1 (de)
AU (1) AU2007200816B2 (de)
CA (1) CA2579333A1 (de)
DE (1) DE602006007211D1 (de)
DK (1) DK1845093T3 (de)
ES (1) ES2327265T3 (de)
PL (1) PL1845093T3 (de)
PT (1) PT1845093E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232252B (it) 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
PT896821E (pt) * 1997-08-08 2003-08-29 Rotta Research Lab Uma nova composicao farmaceutica para inalacao que contem cr 2039 (andolast)
DE602004015788D1 (de) 2004-08-19 2008-09-25 Rottapharm Spa Verwendung von Phenylbenzamide-derivaten zur Behandlung von chronisch-obstruktiver Lungenerkrankung (COPD)

Also Published As

Publication number Publication date
EP1845093B1 (de) 2009-06-10
PL1845093T3 (pl) 2009-11-30
ATE433443T1 (de) 2009-06-15
US7824710B2 (en) 2010-11-02
EP1845093A1 (de) 2007-10-17
AU2007200816A1 (en) 2007-10-25
US20070149586A1 (en) 2007-06-28
AU2007200816B2 (en) 2012-11-01
ES2327265T3 (es) 2009-10-27
PT1845093E (pt) 2009-08-17
DK1845093T3 (da) 2009-09-14
CA2579333A1 (en) 2007-10-10
JP2007277228A (ja) 2007-10-25
US20110086896A1 (en) 2011-04-14
JP5265876B2 (ja) 2013-08-14

Similar Documents

Publication Publication Date Title
ES2314593T3 (es) Forma cristalina alfa de ranelato de estroncio, su procedimiento de preparacion y composiciones farmaceuticas que la contienen.
ES2362788T3 (es) Compuesto de indolina y proceso para la producción del mismo.
HRP20161477T1 (hr) Ligandi koji vežu opsin, pripravci i postupci uporabe
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
HUP0400781A2 (hu) Eljárás (R)- vagy (S)-lansoprazol kristályosítására, az előállított kristályok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE425170T1 (de) Kristallformen der zoledronsäure und deren natrioumsalze, amorphes natriumzoledronat und verfahren zu deren herstellung
CY1112276T1 (el) Παραγωγα (3-αμινο-1,2,3,4-τετραϋδρο-9h-καρβαζολ-9-υλ)- οξικου οξεος
ATE433443T1 (de) Neue kristalline und stabile form von andolast
AR056721A1 (es) Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato
Fini et al. Thermal analysis of some diclofenac salts with alkyl and alkylhydroxy amines
HUP0101230A2 (hu) Eljárás 2-[(2-piridil)-metilszulfinil]-1H-benzimidazol-származékok előállítására
DE60224145D1 (de) Suplatast tosilat kristalle
RU2009126578A (ru) Термочувствительный раствор фосфата алюминия, способ его получения и его применение
Murugan et al. Control of Liquid–Liquid Phase Separation, Nucleation, and Growth of L‐Menthol Single Crystals from Water–Ethanol Solvent Mixtures
PE20010209A1 (es) Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas
PE20010155A1 (es) Polimorfos de un citrato de azobiciclo [2.2.2]oct-3-ilamina cristalino y sus composiciones farmaceuticas
ES2441970T3 (es) Método para producir lansoprazol
Pope et al. LXXIX.—The alkaloidal salts of phenylmethylphosphinic acid
EP3927692A1 (de) Erstarrungs- oder kristallisationsverfahren
NO20083000L (no) Tetomilast polymorfer
US1678317A (en) Manufacture of easily-soluble anaesthetics of the metaaminobenzoic acid ester series
TH68935A (th) อนุพันธ์อินโดลิล
ATE522505T1 (de) Benzensulfonamid-verbindungen zur behandlung von erkrankungen, die auf dopamin-d3- rezeptormodulation ansprechen
TH105399B (th) อนุพันธ์ออกซาไดแอโซลและการใช้สารเหล่านี้เป็นเมทาโบโทรปิกกลูตาเมท รีเซพเตอร์ โพเทนชิเอเตอร์-842
TH76969A (th) สารประกอบชนิดใหม่

Legal Events

Date Code Title Description
8364 No opposition during term of opposition